These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25210168)

  • 1. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.
    Cohen K; Altfeld M; Alter G; Stamatatos L
    J Virol; 2014 Nov; 88(22):13310-21. PubMed ID: 25210168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating CXCR5
    Martin-Gayo E; Cronin J; Hickman T; Ouyang Z; Lindqvist M; Kolb KE; Schulze Zur Wiesch J; Cubas R; Porichis F; Shalek AK; van Lunzen J; Haddad EK; Walker BD; Kaufmann DE; Lichterfeld M; Yu XG
    JCI Insight; 2017 Jan; 2(2):e89574. PubMed ID: 28138558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.
    Ranasinghe S; Soghoian DZ; Lindqvist M; Ghebremichael M; Donaghey F; Carrington M; Seaman MS; Kaufmann DE; Walker BD; Porichis F
    J Virol; 2015 Dec; 90(5):2208-20. PubMed ID: 26656715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
    Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
    Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1.
    Sather DN; Carbonetti S; Malherbe DC; Pissani F; Stuart AB; Hessell AJ; Gray MD; Mikell I; Kalams SA; Haigwood NL; Stamatatos L
    J Virol; 2014 Nov; 88(22):12968-81. PubMed ID: 25122781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
    Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses.
    Nicholas KJ; Flaherty DK; Smith RM; Sather DN; Kalams SA
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):72-80. PubMed ID: 27509243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors.
    Swathirajan CR; Nandagopal P; Vignesh R; Srikrishnan AK; Goyal R; Qureshi H; Saravanan S; Solomon SS; Hanna LE; Sivasankaran MP; Singla N; Mukherjee J; Chatrath S; Kopycinski J; Murugavel KG
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31505637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection.
    Elsner RA; Ernst DN; Baumgarth N
    J Virol; 2012 Jul; 86(13):7146-57. PubMed ID: 22532671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.
    Kobie JJ; Alcena DC; Zheng B; Bryk P; Mattiacio JL; Brewer M; Labranche C; Young FM; Dewhurst S; Montefiori DC; Rosenberg AF; Feng C; Jin X; Keefer MC; Sanz I
    PLoS One; 2012; 7(4):e35356. PubMed ID: 22530008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.
    Borrow P; Moody MA
    Immunol Rev; 2017 Jan; 275(1):62-78. PubMed ID: 28133804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.
    Perreau M; Savoye AL; De Crignis E; Corpataux JM; Cubas R; Haddad EK; De Leval L; Graziosi C; Pantaleo G
    J Exp Med; 2013 Jan; 210(1):143-56. PubMed ID: 23254284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
    Roider J; Porterfield JZ; Ogongo P; Muenchhoff M; Adland E; Groll A; Morris L; Moore PL; Ndung'u T; Kløverpris H; Goulder PJR; Leslie A
    Front Immunol; 2019; 10():1497. PubMed ID: 31333650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.
    Ditse Z; Muenchhoff M; Adland E; Jooste P; Goulder P; Moore PL; Morris L
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint modulation enhances HIV-1 antibody induction.
    Bradley T; Kuraoka M; Yeh CH; Tian M; Chen H; Cain DW; Chen X; Cheng C; Ellebedy AH; Parks R; Barr M; Sutherland LL; Scearce RM; Bowman CM; Bouton-Verville H; Santra S; Wiehe K; Lewis MG; Ogbe A; Borrow P; Montefiori D; Bonsignori M; Anthony Moody M; Verkoczy L; Saunders KO; Ahmed R; Mascola JR; Kelsoe G; Alt FW; Haynes BF
    Nat Commun; 2020 Feb; 11(1):948. PubMed ID: 32075963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.
    Boswell KL; Paris R; Boritz E; Ambrozak D; Yamamoto T; Darko S; Wloka K; Wheatley A; Narpala S; McDermott A; Roederer M; Haubrich R; Connors M; Ake J; Douek DC; Kim J; Petrovas C; Koup RA
    PLoS Pathog; 2014 Jan; 10(1):e1003853. PubMed ID: 24497824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.
    Boliar S; Murphy MK; Tran TC; Carnathan DG; Armstrong WS; Silvestri G; Derdeyn CA
    J Virol; 2012 Aug; 86(15):8031-40. PubMed ID: 22623771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
    Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.
    Gray ES; Madiga MC; Hermanus T; Moore PL; Wibmer CK; Tumba NL; Werner L; Mlisana K; Sibeko S; Williamson C; Abdool Karim SS; Morris L;
    J Virol; 2011 May; 85(10):4828-40. PubMed ID: 21389135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.